I don't mean to demean or malign your report. The answer to your question though just seems like a really easy get. Even if I only had $100K invested in IPIX, and a doctor with a lot of knowledge about antibiotics told me that he knew about significant safety issues with Brilacidin in its clinical trials, well criminy, he couldn't kick me out of the clinic until he'd shown and told me everything he knows about the subject.
If your doc has his drug candidates confused, you can double your share count tomorrow morning and get your basis to less than $1.00 for, probably, less than $8K.
Market Data 
Markets 
AI
